Adam Davidson, CEO of Trident Royalties, discusses offtake milestones and catalysts to boost FY24. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBiome Tech Regulatory News (BIOM)

Share Price Information for Biome Tech (BIOM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 76.00
Bid: 60.00
Ask: 75.00
Change: 6.00 (8.57%)
Spread: 15.00 (25.00%)
Open: 70.00
High: 76.00
Low: 67.50
Prev. Close: 70.00
BIOM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

25 Jan 2023 07:00

RNS Number : 7489N
Biome Technologies PLC
25 January 2023
 

The information contained within this announcement is deemed by the Company to constitute inside information for the purposes of Regulation 11 of the Market Abuse (Amendment) (EU Exit) Regulations 2019/310.

 

25 January 2023

 

Biome Technologies plc

("Biome", the "Company" or the "Group")

 

Trading Update

 

Biome Technologies plc, a leading bioplastics and radio frequency technology business, today provides an unaudited pre-close Trading Update for the financial year ended 31 December 2022.

 

Group revenues for the year ended 31 December 2022 were in line with current market expectations at £6.2m and 10% ahead of the previous year (2021: £5.7m).

 

The Group had a cash balance at the year-end of £0.8m, which is also ahead of those expectations (31 December 2021: £1.0m). This was supported by a reduction of working capital in the Group's supply chain and prompt payments from customers. The Group continues to have no external bank borrowings.

 

The Board anticipates that, subject to audit, the Group will generate a loss before interest, taxation, depreciation, amortisation and share option charges for the year ended 31 December 2022 that is in line with current market expectations.

 

The Group's preliminary results for the year ended 31 December 2022 are scheduled to be published on 26 April 2023.

 

Bioplastics Division

 

The division's revenues for the year to 31 December 2022 were £4.4m (2021: £4.8m). As set-out in previous Trading Updates, this reflected the large reductions in demand for a single long-standing customer of Biome's materials used in packaging films. This was offset substantially by orders from new customers in both North America and Europe primarily related to film products.

 

Constraints which had been impacting orders from a second US end customer following its conversion to our biodegradable coffee filtration did clear, as expected, and a substantial increase of order quantities were received for delivery in Q4 2022. Encouragingly, this increased demand has continued into 2023 and is underpinning divisional revenues for Q1.

 

The further important opportunities detailed in the 10 November 2022 Trading Update, but not included at scale in management's expectations for 2023 continue broadly as expected, but with no clear timetable to revenue delivery as yet.

 

Stanelco RF Technologies Division

 

Revenues in the RF Technologies division in 2022 were £1.8m (2021: £0.9m). This uplift was driven by substantial orders both for fibre optic furnaces and wider industrial applications won in late 2021 and early 2022.

 

The division enters 2023 with several significant prospects for 2023, but with a much lower confirmed order book than at this time in 2022. Therefore, we believe it is prudent to reduce our expectations for the RF Technologies division in the current year, pending the finalisation of further customer discussions.

 

Group Outlook

 

Whilst we are cautious in our expectations for the RF division, particularly in the current economic environment, the team is working hard to convert its prospect pipeline into firm orders. The Bioplastics division has started 2023 in an encouraging manner. The Board looks forward to providing an update on the Group's performance at the time of the full year results in April.

 

-Ends-

 

For further information please contact:

Biome Technologies plc

Paul Mines, Chief Executive Officer

Rob Smith, Chief Financial Officer

www.biometechnologiesplc.com

Tel: +44 (0) 2380 867 100

 

Allenby Capital

David Hart/Alex Brearley (Nominated Adviser)

Kelly Gardiner (Sales and Corporate Broking)

www.allenbycapital.com

Tel: +44 (0) 20 3328 5656

 

About Biome

Biome Technologies plc is an AIM listed, growth-orientated, commercially driven technology group. Our strategy is founded on building market-leading positions based on patented technology and serving international customers in valuable market sectors. We have chosen to do this by developing products in application areas where the value-added pricing can be justified and are not reliant on government legislation. These products are driven by customer requirements and are compatible with existing manufacturing processes. They are market rather than technology-led.

 

The Group comprises two divisions, Biome Bioplastics Limited ("Bioplastic") and Stanelco RF Technologies Limited ("RF Technologies").

 

Biome Bioplastics is a leading developer of highly-functional, bio-based and biodegradable plastics. The company's mission is to produce bioplastics that challenge the dominance of oil- based polymers.

 

Stanelco RF Technologies designs, builds and services advanced radio frequency (RF) systems. Dielectric and induction heating products are at the core of a product offering that ranges from portable sealing devices to large furnaces for the fibre optics markets.

 

www.biometechnologiesplc.com www.biomebioplastics.com and www.thinkbioplastic.com www.stanelcorftechnologies.com

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTNKQBPFBKDADB
Date   Source Headline
25th Mar 20207:00 amRNSUpdate re Final Results, 2019 Annual Report & AGM
13th Feb 20204:01 pmRNSNotification of awards under the 2017 LTIP
30th Jan 20204:10 pmRNSShare option awards in lieu of historic bonuses
30th Jan 20207:00 amRNSTrading statement and Board change
4th Nov 20197:00 amRNSBiome to present at Mello London 2019
31st Oct 20195:30 pmRNSTotal Voting Rights
31st Oct 20197:00 amRNSTrading update
30th Sep 20193:04 pmRNSResult of General Meeting
12th Sep 20197:05 amRNSProposed Placing to raise £1.3 million
12th Sep 20197:00 amRNSInterim Results
22nd Jul 20197:00 amRNSTrading Update
25th Jun 20199:17 amRNSLong Term Incentive Plan Second Vesting
17th Jun 20194:12 pmRNSDirector/PDMR/PCA Shareholding
14th Jun 20197:00 amRNSBioplastics Product Update
24th Apr 20191:59 pmRNSResult of Annual General Meeting
24th Apr 20197:00 amRNSTrading Update
4th Apr 201912:20 pmRNSDirector/PDMR/PCA Shareholding
29th Mar 20199:22 amRNSNotice of AGM and Annual Report
28th Mar 20197:00 amRNSPreliminary Results
27th Mar 20192:05 pmRNSSecond Price Monitoring Extn
27th Mar 20192:00 pmRNSPrice Monitoring Extension
13th Mar 20191:54 pmRNSHoldings in Company
24th Jan 20197:00 amRNSPre-close Trading Statement
31st Dec 20187:00 amRNSTotal Voting Rights
10th Dec 20182:35 pmRNS2017 Long Term Incentive Plan - First Vesting
6th Dec 20187:00 amRNSGrant funding from Innovate UK
23rd Nov 201812:38 pmRNSBiome to present at Mello London
1st Nov 20187:00 amRNSTrading update
3rd Sep 20187:00 amRNSInterim Results
23rd Jul 20187:00 amRNSTrading Update
31st May 20185:00 pmRNSTotal Voting Rights
2nd May 20184:13 pmRNSIssue of shares to directors & PDMR shareholdings
2nd May 20183:27 pmRNSProposed issue of shares to directors and dealings
24th Apr 201810:40 amRNSResult of Annual General Meeting
24th Apr 20187:00 amRNSTrading update
28th Mar 20181:52 pmRNSNotice of AGM and Annual Report and Accounts
27th Mar 20187:00 amRNSPreliminary Results
19th Feb 20182:05 pmRNSSecond Price Monitoring Extn
19th Feb 20182:00 pmRNSPrice Monitoring Extension
25th Jan 20187:00 amRNSPre-close Trading Statement
21st Dec 20177:00 amRNSNew LTIP and option grant
1st Nov 20177:00 amRNSTrading Update
4th Sep 20177:00 amRNSHalf-year Report
26th Jul 20179:30 amRNSDirector/PDMR Shareholding
25th Jul 20174:50 pmRNSDirector/PDMR Shareholding
24th Jul 20177:00 amRNSTrading Update
24th Apr 201710:45 amRNSResult of AGM
24th Apr 20177:00 amRNSTrading Update
31st Mar 20172:50 pmRNSNotice of AGM and Annual Report and Accounts
29th Mar 20177:00 amRNSPreliminary Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.